An organized set of primary and secondary sources covering clinical background, drug-safety signals, and patient-safety considerations.
Understanding the Aromatase Inhibitor-Bone Density Loss connection Resource Guide — detailed background and analysis.
Reference: Centers for Disease Control and Prevention (CDC)
Authoritative source for clinical, regulatory, and public-health background reading.
Reference: World Health Organization (WHO)
Authoritative source for clinical, regulatory, and public-health background reading.
Reference: Mayo Clinic — Diseases & Conditions
Authoritative source for clinical, regulatory, and public-health background reading.